Cargando…
Insulin glargine 300 U/mL in the management of diabetes: clinical utility and patient perspectives
There is ongoing interest in optimizing basal insulin treatment by developing insulins with a flat pharmacological profile, a long duration of action (typically beyond 24 hours) and minimum day-to-day variation. Glargine-300 is a modified form of the long-acting insulin analog glargine in that it ha...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074702/ https://www.ncbi.nlm.nih.gov/pubmed/27799746 http://dx.doi.org/10.2147/PPA.S92123 |